Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer

Fig. 1

Genetic instrument construction, data sources, and analysis plan in a study of associations about the inhibition of HMG-CoA reductase, NPC1L1 and PCSK9 on breast cancer and prostate cancer. HMG-CoA reductase, 3-hydroxy-3-methylglutaryl coenzyme A; NPC1L1, Niemann-Pick C1-Like 1; PCSK9, proprotein convertase subtilisin/kexin type 9; BCAC database, The Breast Cancer Association Consortium; PRACTICAL database, Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome Consortium; ER, estrogen receptor

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us